Douglas Rosefsky

Douglas Rosefsky has extensive work experience in the private equity, finance, and corporate turnaround industries. From 1999 to 2015, they were a Managing Director, Partner, and member of the European Executive Committee of Alvarez & Marsal France. In 2016, they became a Founding Partner of Prudentia Capital, a French fund management company. In 2018, they became a Non-Executive Director and Chairman of the Audit Committee for AOBiome Therapeutics, Inc. In 2020, they became a Senior Advisor for Tikehau Capital, a Non-Executive Director for SCP Retail Investments, and a Non-Executive Director for Synergie-Cad. In 2022, they became an Investment Partner for The SCP Group and a Member of the Board for ARE (Association pour le Retournement des Entreprises). Additionally, they have been an Adjunct Professor at INSEAD since 2013, teaching MBA, Global Executive MBA, and Executive Education programs.

Douglas Rosefsky's education history includes attending The Taft School from 1983 to 1986, Duke University from 1986 to 1990, where they obtained a BA in Economics and Computer Science, and The Wharton School from 1993 to 1995, where they obtained an MBA in Finance. Douglas also attended HEC Paris and INSEAD, but did not obtain any additional certifications.